Arrowhead Research Corp

Type: Company
Name: Arrowhead Research Corp
First reported 5 hours ago - Updated 4 hours ago - 1 reports

5 Stocks Poised for Big Breakouts

DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players who can ... [Published The Street Latest - 5 hours ago]
First reported Aug 30 2014 - Updated Aug 30 2014 - 1 reports

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Arrowhead Research Is Up 12.1% (ARWR)

(Financial News Network On) Two weeks ago on August 12th, 2014 Arrowhead Research (NASDAQ:ARWR) reported earnings and analysts, on average, expected a loss of $0.22 on sales of $43.0 thousand. Arrowhead Research actually reported a loss of $0.22 per ... [Published Individual.com - Aug 30 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Arrowhead Research Shares Climbing Higher, Up 4.0%

Written on Fri, 08/29/2014 - 12:30pmBy David DiazOne of today's stocks on the move is Arrowhead Research ( NASDAQ:ARWR ), up 4.0% to $14.71. The Dow is trading fractionally higher to 17,094 and the S&P is currently up 0.3% to 2,002.Arrowhead Research ... [Published Comtex SmarTrend - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 29 2014 - 1 reports

Arrowhead Research Shares Sinking Lower,...

Arrowhead Research (NASDAQ:ARWR) is a company whose shares are active, trading 3.5% lower to $14.25. The Dow Jones Industrial Average is now trading fractionally lower to 17,093 and the S&P is trading fractionally lower to 1,998.In the past 52 weeks, ... [Published Financial News Network online - Aug 28 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Friday's ETF Movers: XBI, PIZ

In trading on Friday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1% on the day. Components of that ETF showing particular strength include shares of United Therapeutics (UTHR), up about 15.9% and shares of Arrowhead Research ... [Published Street Sweeper - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead

NEW YORK, August 29, 2014 /PRNewswire/ --Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: ... [Published PR Newswire: Entertainment & Media - Aug 29 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Quiet Before the Holiday Weekend (Morning Call Express)

World markets are pretty quiet needing some digestion as we head towards the holiday weekend. The Gaza ceasefire is holding and there seemed to be a constructive meeting in the Ukraine. Europe is holding its move off the recent low and Asia continues ... [Published T3 Live - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 27 2014 - 2 reports

Tuesday's ETF Movers: XBI, XLU

at 13:15 PM EDT In trading on Tuesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.2% on the day. Components of that ETF showing particular strength include shares of Arrowhead Research (ARWR), up about 12.3% and shares of Isis ... [Published NewsOK.com - Aug 26 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver

CHICAGO, Aug. 27, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ... [Published PR Newswire: Financial Services - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 4 reports

Arrowhead Research is a prime acquisition target

Deutsche Bank analysts said that Arrowhead Research Corp. (Nasdaq: ARWR) was a good target for an acquisition sending the stock price up $1.76 to close at $15.2 ... [Published Chicago Daily Herald - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Rating Upgrade Gives Enphase Energy Inc a Boost

Arrowhead Research Corp (NASDAQ: ARWR ), Enphase Energy Inc (NASDAQ: ENPH ) and ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS ) are today’s top midday gainers on Wall Street. On the losing end are Adept Technology Inc (NASDAQ: ADEP ), 21Vianet Group Inc (NASDAQ: ... [Published Value Walk - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Deutsche Bank Sees Achillion, Arrowhead As Potential Takeover Targets

Achillion Pharmaceuticals (NASDAQ: ACHN) and Arrowhead Research (NASDAQ: ARWR) were up sharply Tuesday after an analyst said the pair of drug development companies could become takeover targets."If you want to compete with Gilead, you have to buy Achillion," ... [Published Benzinga.com - Aug 26 2014]

Quotes

"If you want to compete with Gilead, you have to buy Achillion" Deutsche Bank's Robyn Karnauskas said on CNBC. "We think that's one take-out target."
Pioneer Natural Resources (NYSE:PXD): "The oil complex is going down. This is going down."
Now I would have to update that call and say "buy in the $80s and don't miss those dips into the $70s."
Original Article: NEXT ARTICLE More From BioPortfolio on "Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential"

More Content

All (145) | News (101) | Reports (0) | Blogs (35) | Audio/Video (0) | Fact Sheets (0) | Press Releases (8)
sort by: Date | Relevance
5 Stocks Poised for Big Breakouts [Published The Street Latest - 5 hours ago]
The Second Coming of RNAi [Published The Scientist - 7 hours ago]
Earnings Flashback: Since Reporting Quarterly R... [Published Individual.com - Aug 30 2014]
Friday's ETF Movers: XBI, PIZ [Published Street Sweeper - Aug 29 2014]
Arrowhead Research Shares Climbing Higher, Up 4.0% [Published Comtex SmarTrend - Aug 29 2014]
Friday's ETF Movers: XBI, PIZ [Published Forbes.com - Aug 29 2014]
Upcoming Conferences, Market Activity, Drug App... [Published PR Newswire: Entertainment & Media - Aug 29 2014]
Arrowhead Research Shares Sinking Lower,... [Published Financial News Network online - Aug 28 2014]
Quiet Before the Holiday Weekend (Morning Call ... [Published T3 Live - Aug 27 2014]
Achillion Pharmaceuticals, Inc. (ACH) Bulls Eye... [Published Schaeffers Research - Aug 27 2014]
Critical Alerts For Arrowhead Research, Isis Ph... [Published PR Newswire: Financial Services - Aug 27 2014]
S&P closes at record 2000 [Published Indianapolis Business Journal - Aug 26 2014]
Arrowhead Research is a prime acquisition target [Published Chicago Daily Herald - Aug 26 2014]
Leading Health Care Stock for Small-Cap Stars i... [Published Equities.com - Aug 26 2014]
Rating Upgrade Gives Enphase Energy Inc a Boost [Published Value Walk - Aug 26 2014]
Arrowhead Research (ARWR) Stock Rises on High V... [Published TheStreet.com - Aug 26 2014]
Arrowhead Research (ARWR) Stock Rises on High V... [Published The Street Latest - Aug 26 2014]
Wet Seal Inc. (WTSL) Leads Small-Cap Stars in E... [Published Equities.com - Aug 26 2014]
Leading Small-Cap Stars Health Care Stock for A... [Published Equities.com - Aug 26 2014]
Tuesday's ETF Movers: XBI, XLU [Published NewsOK.com - Aug 26 2014]
Deutsche Bank Sees Achillion, Arrowhead As Pote... [Published Benzinga.com - Aug 26 2014]
Tuesday's ETF Movers: XBI, XLU [Published Forbes.com - Aug 26 2014]
Relatively Good Performance Detected in Shares ... [Published Comtex SmarTrend - Aug 26 2014]
'Fast Money' Recap: Next Stop, S&P 2,100? [Published TheStreet.com - Aug 26 2014]
'Fast Money' Recap: Next Stop, S&P 2,100? [Published The Street Latest - Aug 26 2014]
Leading Small-Cap Stars Health Care Stock for A... [Published Equities.com - Aug 25 2014]
Arrowhead Research Shares Climbing Higher, Up 5.7% [Published Comtex SmarTrend - Aug 25 2014]
Provectus Biopharmaceuticals Inc. (PVCT) Leads ... [Published 4 Traders - Aug 22 2014]
Look for Shares of Arrowhead Research to Potent... [Published Comtex SmarTrend - Aug 21 2014]
Shares of Arrowhead Research Under Press... [Published Financial News Network online - Aug 21 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Upcoming Conferences, Market Activity, Drug App... [Published PR Newswire: Entertainment & Media - Aug 29 2014]
NEW YORK, August 29, 2014 /PRNewswire/ --Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: ...
Critical Alerts For Arrowhead Research, Isis Ph... [Published PR Newswire: Financial Services - Aug 27 2014]
CHICAGO, Aug. 27, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ...
Arrowhead Reports Fiscal 2014 Third Quarter Fin... [Published Business Wire Health News - Aug 12 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on the Phase 2a study ARC-520 for the treatment of chronic hepatitis b infection ...
Arrowhead to Report Fiscal 2014 Third Quarter F... [Published Business Wire Health News - Jul 31 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will Report Fiscal 2014 Third Quarter Financial Results and hold a Conference Call on Tuesday, August 12, 2014 ...
Arrowhead Announces New Clinical Candidate ARC-... [Published Business Wire Health News - Jun 19 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research announces new RNAi candidate ARC-AAT to treat alpha-1 antitrypsin deficiency and holds analyst day to present data ...
1 2 3 4 5 6 7

Press Releases

sort by: Date | Relevance
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
SEC Filings, Positive Trial Results, Technical ... [Published Financial Services - Jul 18 2014]
Technical Updates, License Agreements, and Acqu... [Published Financial Services - Jul 08 2014]
Clinical Studies, Trials Results, Appointments,... [Published Financial Services - Jun 27 2014]
Strategic Acquisitions, Clinical Data Presentat... [Published Financial Services - Jun 06 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.